Report Cover

North America Bioreactors Market Size By Technology, Molecule, End-use,Cell, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025


Development of orphan drugs and personalized medicine should provide effective healthcare solutions by improvements in diagnosis, treatment, and monitoring of chronic diseases. Increasing number of personalized medicines targeting a specific population coupled with rising number of FDA approved orphan drugs has increased bioproduction, accelerating the bioreactors demand over the forecast years.A North America Bioreactors Market ShareA estimated to exceed USD 790 million by 2025.

Rising prevalence of chronic diseases, and growing biopharmaceutical investments will drive the global bioreactors market size. Increasing demand for therapeutically effective vaccines, product innovation, and favorable government initiatives to improve healthcare infrastructure will further stimulate business growth. Moreover, various advancements in tank design to meet the growing needs of biopharmaceutical industry will be conducive to the market growth.

However, regulatory concerns regarding single-use bioreactor, vulnerability to leaching, and limited storage capacity should hinder bioreactor market growth. Additionally, large-scale disposal of plastic derivatives is a growing environmental concern restraining the business growth over the forecast years.

Mammalian cells segment is estimated to expand at 17.9% CAGR over the forecast timeframe, owing to its wide application in production of viral vaccines and therapeutic proteins. Additionally, emergence of gene therapy and tissue engineering coupled with demand for smart and regenerative medicine should boost the industry growth over the forecast years.

Monoclonal antibodies (mAb) generated over USD 100 million in 2018 owing to its increasing application in treatment of breast cancers, asthma, rheumatoid arthritis, leukemia, psoriasis chronic gastrointestinal inflammatory disease, and transplant rejection. Novel bioreactors that meet specific demands for mAb production will accelerate the segment growth.

Wave-induced motion SUB segment is expected to witness substantial growth rate of 17.3% across the forecast timeframe. High growth is attributed to extensive use in modern biotechnological processes. It is mainly used in laboratory and pilot plant scale-up owing to better flexibility with adequate productivity. Furthermore, increasing focus of manufacturers in the development of advanced technology related to bioreactors will propel market growth.

R&D organizations segment was valued at USD 127.9 million in 2018 and is projected to witness strong growth over the forecast years. High growth is attributed to increase in number of biopharmaceutical products in pipeline including antibodies and antibody drug conjugates coupled with rising number of new facilities to meet the production needs. Furthermore, large biopharmaceutical companies and biosimilar producers are entering strategic collaborations with new entrants to facilitate business expansion.

North America bioreactors market was led by U.S. bioreactors market and is estimated to show a positive trend throughout the projection period. Canada bioreactors business is forecasted to follow U.S. bioreactors market progressing at 17.9% CAGR throughout the forecast timeframe. High growth is attributed to factors such as presence of major market players, increasing application of single use bioreactor in biopharmaceutical companies and technological innovations to develop disposable bioreactor.

Major market players in North America bioreactors market are Thermo Fisher Scientific, PBS Biotech, GE Healthcare, Merck Group, Cellexus Ltd, Sartorius Stedim Biotech Group and Applikon Biotechnology, Inc., These market players are undertaking strategies such as technology development and acquisitions to gain market presence for company expansion.
Report Content

Chapter 1.   Methodology

1.1.   Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters        

1.2.   Data sources 

1.3.   References    sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.  Executive Summary

2.1.   North America bioreactors industry summary, 2014 - 2025

2.1.1.  Country trends

2.1.2.  Cell trends

2.1.3.  Molecule trends

2.1.4.  Technology trends

2.1.5.  End-use trends

Chapter 3.  Industry Insights

3.1.   Industry segmentation

3.2.   Industry outlook, 2014 - 2025

3.3.   Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Growing biopharmaceuticals and biologics industry

3.3.1.2.   Technological advancements in bioreactors

3.3.1.3.   Growing orphan drugs developments

3.3.1.4.   Increasing demand for personalized medicines

3.3.2.  Restraints    challenges

3.3.2.1.   Low capacity of single-use bioreactor

3.3.2.2.   Concerns regarding extractables and/or leachable

3.4.   Regulatory landscape

3.4.1.  U.S.

3.4.2.  Canada

3.5.   Technology landscape

3.6.   Porter's analysis

3.7.   Competitive review, 2017

3.8.   PEST analysis

Chapter 4.   North America Bioreactors Market, By Cell

4.1.   Key trends in North America bioreactors, by cell

4.2.   Mammalian cells

4.2.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

4.3.   Bacterial cells

4.3.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

4.4.   Yeast cells

4.4.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

4.5.   Others

4.5.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

Chapter 5.   North America Bioreactors Market, By Molecule

5.1.   Key trends in North America bioreactors, by molecule

5.2.   Monoclonal antibodies

5.2.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

5.3.   Vaccines

5.3.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

5.4.   Recombinant protein

5.4.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

5.5.   Stem cell

5.5.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

5.6.   Gene therapy

5.6.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

5.7.   Others

5.7.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

Chapter 6.  North America Bioreactors Market, By Technology

6.1.   Key trends in North America bioreactors, by technology

6.2.   Wave-induced motion SUB

6.2.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

6.3.   Stirred SUB

6.3.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

6.4.   Stirred-use bubble column

6.4.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

6.5.   Others

6.5.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

Chapter 7.   North America Bioreactors Market, By End-use

7.1.   Key trends in North America bioreactors, by end-use

7.2.   Research and development (R&D) organizations

7.2.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

7.3.   Biopharma manufacturers

7.3.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

7.4.   Contract manufacturing organizations (CMOs)

7.4.1.  Market estimates and forecast, by country, 2014 - 2025 (USD Million)

Chapter 8.  North America Bioreactors Market, By Country

8.1.   Key trends in North America bioreactors, by country

8.2.   U.S.

8.2.1.   Market estimates and forecast, 2014 - 2025 (USD Million)

8.2.2.   Market estimates and forecast, by cell, 2014 - 2025 (USD Million)

8.2.3.   Market estimates and forecast, by molecule, 2014 - 2025 (USD Million)

8.2.4.   Market estimates and forecast, by technology, 2014 - 2025 (USD Million)

8.2.5.   Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)

8.3.   Canada

8.3.1.   Market estimates and forecast, 2014 - 2025 (USD Million)

8.3.2.   Market estimates and forecast, by cell, 2014 - 2025 (USD Million)

8.3.3.   Market estimates and forecast, by molecule, 2014 - 2025 (USD Million)

8.3.4.   Market estimates and forecast, by technology, 2014 - 2025 (USD Million)

8.3.5.   Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)

Chapter 9.  Company Profiles

9.1.   Thermo Fisher Scientific

9.1.1.  Business overview

9.1.2.  Financial data

9.1.3.  Product landscape

9.1.4.  Strategic outlook

9.1.5.  SWOT analysis

9.2.   PBS Biotech

9.2.1.  Business overview

9.2.2.  Financial data

9.2.3.  Product landscape

9.2.4.  Strategic outlook

9.2.5.  SWOT analysis

9.3.   GE Healthcare

9.3.1.  Business overview

9.3.2.  Financial data

9.3.3.  Product landscape

9.3.4.  Strategic outlook

9.3.5.  SWOT analysis

9.4.   Merck Group

9.4.1.  Business overview

9.4.2.  Financial data

9.4.3.  Product landscape

9.4.4.  Strategic outlook

9.4.5.  SWOT analysis

9.5.   Cellexus Ltd

9.5.1.  Business overview

9.5.2.  Financial data

9.5.3.  Product landscape

9.5.4.  Strategic outlook

9.5.5.  SWOT analysis

9.6.   Pall Corporation

9.6.1.  Business overview

9.6.2.  Financial data

9.6.3.  Product landscape

9.6.4.  Strategic outlook

9.6.5.  SWOT analysis

9.7.   Sartorius Stedim Biotech Group

9.7.1.  Business overview

9.7.2.  Financial data

9.7.3.  Product landscape

9.7.4.  Strategic outlook

9.7.5.  SWOT analysis

9.8.   Applikon Biotechnology, Inc.

9.8.1.   Business overview

9.8.2.   Financial data

9.8.3.   Product landscape

9.8.4.   Strategic outlook

9.8.5.   SWOT analysis

9.9.   GEA Group Aktiengesellschaft

9.9.1.   Business overview

9.9.2.   Financial data

9.9.3.   Product landscape

9.9.4.   Strategic outlook

9.9.5.   SWOT analysis

9.10. BioTron, Inc.

9.10.1. Business overview

9.10.2. Financial data

9.10.3. Product landscape

9.10.4. Strategic outlook

9.10.5. SWOT analysis

9.11. Eppendorf AG

9.11.1. Business overview

9.11.2. Financial data

9.11.3. Product landscape

9.11.4. Strategic outlook

9.11.5. SWOT analysis

9.12. Solaris Biotech Solutions

9.12.1. Business overview

9.12.2. Financial data

9.12.3. Product landscape

9.12.4. Strategic outlook

9.12.5. SWOT analysis

 

Data Tables

TABLE 1.          North America market estimates by country, (USD Mn), 2014 - 2018

TABLE 2.          North America market forecast by country, (USD Mn), 2019 - 2025

TABLE 3.          North America market estimates by cell, (USD Mn), 2014 - 2018

TABLE 4.          North America market forecast by cell, (USD Mn), 2019 - 2025

TABLE 5.          North America market estimates by molecule, (USD Mn), 2014 - 2018

TABLE 6.          North America market forecast by molecule, (USD Mn), 2019 - 2025

TABLE 7.          North America market estimates by technology, (USD Mn), 2014 - 2018

TABLE 8.          North America market forecast by technology, (USD Mn), 2019 - 2025

TABLE 9.          North America market estimates by end-use, (USD Mn), 2014 - 2018

TABLE 10.        North America market forecast by end-use, (USD Mn), 2019 - 2025

TABLE 11.        Competition review

TABLE 12.        North America mammalian cells market estimates, (USD Mn), 2014 - 2018

TABLE 13.        North America mammalian cells market forecast, (USD Mn), 2019 - 2025

TABLE 14.        North America bacterial cells market estimates, (USD Mn), 2014 - 2018

TABLE 15.        North America bacterial cells market forecast, (USD Mn), 2019 - 2025

TABLE 16.        North America yeast cells market estimates, (USD Mn), 2014 - 2018

TABLE 17.        North America yeast cells market forecast, (USD Mn), 2019 - 2025

TABLE 18.        North America others market estimates, (USD Mn), 2014 - 2018

TABLE 19.        North America others market forecast, (USD Mn), 2019 - 2025

TABLE 20.        North America monoclonal antibodies market estimates, (USD Mn), 2014 - 2018

TABLE 21.        North America monoclonal antibodies market forecast, (USD Mn), 2019 - 2025

TABLE 22.        North America vaccines market estimates, (USD Mn), 2014 - 2018

TABLE 23.        North America vaccines market forecast, (USD Mn), 2019 - 2025

TABLE 24.        North America recombinant protein market estimates, (USD Mn), 2014 - 2018

TABLE 25.        North America recombinant protein market forecast, (USD Mn), 2019 - 2025

TABLE 26.        North America stem cell market estimates, (USD Mn), 2014 - 2018

TABLE 27.        North America stem cell market forecast, (USD Mn), 2019 - 2025

TABLE 28.        North America gene therapy market estimates, (USD Mn), 2014 - 2018

TABLE 29.        North America gene therapy market forecast, (USD Mn), 2019 - 2025

TABLE 30.        North America others market estimates, (USD Mn), 2014 - 2018

TABLE 31.        North America others market forecast, (USD Mn), 2019 - 2025

TABLE 32.        North America wave-induced motion SUB market estimates, (USD Mn), 2014 - 2018

TABLE 33.        North America wave-induced motion SUB market forecast, (USD Mn), 2019 - 2025

TABLE 34.        North America stirred SUB market estimates, (USD Mn), 2014 - 2018

TABLE 35.        North America stirred SUB market forecast, (USD Mn), 2019 - 2025

TABLE 36.        North America stirred-use bubble column market estimates, (USD Mn), 2014 - 2018

TABLE 37.        North America stirred-use bubble column market forecast, (USD Mn), 2019 - 2025

TABLE 38.        North America others monitors market estimates, (USD Mn), 2014 - 2018

TABLE 39.        North America others monitors market forecast, (USD Mn), 2019 - 2025

TABLE 40.        North America research and development (R&D) organizations market estimates, (USD Mn), 2014 - 2018

TABLE 41.        North America research and development (R&D) organizations market forecast, (USD Mn), 2019 - 2025

TABLE 42.        North America biopharma manufacturers market estimates, (USD Mn), 2014 - 2018

TABLE 43.        North America biopharma manufacturers market forecast, (USD Mn), 2019 - 2025

TABLE 44.        North America contract manufacturing organizations (CMOs) market estimates, (USD Mn), 2014 - 2018

TABLE 45.        North America contract manufacturing organizations (CMOs) market forecast, (USD Mn), 2019 - 2025

TABLE 46.        U.S. bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 47.        U.S. bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 48.        U.S. market size by cell, (USD Million), 2014 - 2018

TABLE 49.        U.S. market size by cell, (USD Million), 2019 - 2025

TABLE 50.        U.S. market size by molecule, (USD Million), 2014 - 2018

TABLE 51.        U.S. market size by molecule, (USD Million), 2019 - 2025

TABLE 52.        U.S. market size by technology, (USD Million), 2014 - 2018

TABLE 53.        U.S. market size by technology, (USD Million), 2019 - 2025

TABLE 54.        U.S. market size by end-use, (USD Million), 2014 - 2018

TABLE 55.        U.S. market size by end-use, (USD Million), 2019 - 2025

TABLE 56.        Canada bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 57.        Canada bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 58.        Canada market size by cell, (USD Million), 2014 - 2018

TABLE 59.        Canada market size by cell, (USD Million), 2019 - 2025

TABLE 60.        Canada market size by molecule, (USD Million) 2014 - 2018

TABLE 61.        Canada market size by molecule, (USD Million), 2019 - 2025

TABLE 62.        Canada market size by technology, (USD Million), 2014 - 2018

TABLE 63.        Canada market size by technology, (USD Million), 2019 - 2025

TABLE 64.        Canada market size by end-use, (USD Million), 2014 - 2018

TABLE 65.        Canada market size by end-use, (USD Million), 2019 - 2025

Charts    Figures

FIG 1.     Industry segmentation

FIG 2.     North America bioreactors industry outlook, 2014 - 2025

FIG 3.     Porter's analysis

FIG 4.     PEST analysis


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by Graphical Research

North America Hand Sanitizer Market Size By Type (Gel, Liquid, Foam), By Composition (Alcohol-based Sanitizer, Alcohol-free Sanitizer), By Distribution Channel (Retail {Pharmaceutical Stores, Supermarkets, Convenience Stores}, Online Platform), Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

North America Hand Sanitizer Market Estimated To Exceed USD 1,471 Million By 2026. The surging demand of hand sanitizer in North America will foster the hand sanitizer industry growth. Increasing demand of alcohol-based hand sanitizer due to outbreak...

North America Stationary Battery Storage Market Size By Battery, Application, Industry Analysis Report, Country Outlook, Application Development Potential, Price Trend, Competitive Market Share & Forecast, 2020 a?? 2026

North America Stationary Battery Storage Market Share will witness an upsurge on account of growing investments toward integration of energy efficient technologies coupled with increasing deployment of enhanced storage systems with high power output....

North America Heat Recovery Steam Generator Market Size By Design, Rated Power, Mode of Operation, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market Share & Forecast, 2020 a?? 2026

North America Heat Recovery Steam Generator Market Size is anticipated to grow on account of government regulations to minimize carbon footprints along with adoption of sustainable energy technologies Surging adoption of energy efficient power genera...

Publisher: Graphical Research
Chat with us